Search Results - "Ohsugi, Jun"

Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer by Ozaki, Yuki, Muto, Satoshi, Takagi, Hironori, Watanabe, Masayuki, Inoue, Takuya, Fukuhara, Mitsuro, Yamaura, Takumi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Ohsugi, Jun, Hoshino, Mika, Shio, Yutaka, Tanaka, Daisuke, Nanamiya, Hideaki, Imai, Jun-ichi, Isogai, Takao, Watanabe, Shinya, Suzuki, Hiroyuki

“…Cancer treatment using immune checkpoint inhibitors is widely used, although biomarkers predictive of response are not well established. However, both the…”
Get full text

Increase in dicentric chromosome formation after a single CT scan in adults by Abe, Yu, Miura, Tomisato, Yoshida, Mitsuaki A., Ujiie, Risa, Kurosu, Yumiko, Kato, Nagisa, Katafuchi, Atsushi, Tsuyama, Naohiro, Ohba, Takashi, Inamasu, Tomoko, Shishido, Fumio, Noji, Hideyoshi, Ogawa, Kazuei, Yokouchi, Hiroshi, Kanazawa, Kenya, Ishida, Takashi, Muto, Satoshi, Ohsugi, Jun, Suzuki, Hiroyuki, Ishikawa, Tetsuo, Kamiya, Kenji, Sakai, Akira

“…Excess risk of leukemia and brain tumors after CT scans in children has been reported. We performed dicentric chromosome assay (DCAs) before and after CT scan…”
Get full text

Analysis of chromosome translocation frequency after a single CT scan in adults by Abe, Yu, Miura, Tomisato, Yoshida, Mitsuaki A., Ujiie, Risa, Kurosu, Yumiko, Kato, Nagisa, Katafuchi, Atsushi, Tsuyama, Naohiro, Kawamura, Fumihiko, Ohba, Takashi, Inamasu, Tomoko, Shishido, Fumio, Noji, Hideyoshi, Ogawa, Kazuei, Yokouchi, Hiroshi, Kanazawa, Kenya, Ishida, Takashi, Muto, Satoshi, Ohsugi, Jun, Suzuki, Hiroyuki, Ishikawa, Tetsuo, Kamiya, Kenji, Sakai, Akira

“…We recently reported an increase in dicentric chromosome (DIC) formation after a single computed tomography (CT) scan (5.78–60.27 mSv: mean 24.24 mSv) and we…”
Get full text

Two cases of thymic carcinoid treated with octreotide long-acting repeatable by Okabe, Naoyuki, Inoue, Takuya, Watanabe, Yuzuru, Muto, Satoshi, Hasegawa, Takeo, Ohsugi, Jun, Higuchi, Mitsunori, Shio, Yutaka, Suzuki, Hiroyuki

“…Thymic carcinoid is a rare disease that accounts for 3.1% of thymic tumors and 1.8-6% of all carcinoid tumors in Japan. Advanced thymic carcinoid has a 5-year…”
Get more information

Renal-salt wasting syndrome in a patient with CDDP containing chemotherapy for recurrent non-small-cell lung cancer by Suzuki, Hiroyuki, Ohsugi, Jun, Saito, Takaharu, Hoshino, Mika, Higuchi, Mitsunori, Kitamura, Masatoshi, Kudoh, Akihiro, Midorikawa, Sanae, Gotoh, Mitsukazu

“…Hyponatremia is one of the major side effects that occurs after CDDP-based cancer chemotherapy. However, RSWS has rarely been reported as a cause of…”
Get more information

A Case of Pulmonary Venous Malformation Accidentally Discovered in an Adolescent Boy by Kumazawa, Mariko, Arakawa, Hiroaki, Maeda, Sumiko, Nakazato, Yoshimasa, Ohsugi, Jun, Kaji, Yasushi

Get full text

A Case of Pulmonary Venous Malformation Accidentally Discovered in an Adolescent Boy by Kumazawa, Mariko, Arakawa, Hiroaki, Maeda, Sumiko, Nakazato, Yoshimasa, Ohsugi, Jun, Kaji, Yasushi

Get full text

Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer by Suzuki, Hiroyuki, Higuchi, Mitsunori, Hasegawa, Takeo, Yonechi, Atsushi, Ohsugi, Jun, Yamada, Fumihiko, Hoshino, Mika, Shio, Yutaka, Fujiu, Koichi, Gotoh, Mitsukazu

“…A clinical significance of the aberrant expression of HLA class I molecules including HLA class I and HLA-G was analyzed using tissue array analysis. Our…”
Get more information

Correlation between mutation burden of tumor and immunological/clinical parameters in considering biomarkers of immune checkpoint inhibitors for non-small cell lung cancer (NSCLC) by Owada, Yuki, Muto, Satoshi, Takagi, Hironori, Inoue, Takuya, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Ohsugi, Jun, Tanaka, Daisuke, Ito, Emi, Nanamiya, Hideaki, Imai, Jun-ichi, Isogai, Takao, Watanabe, Shinya, Suzuki, Hiroyuki

“…Abstract only e23184 Background: There has been reported that mutation burden of solid tumor might probably be a predictive biomarker of efficacy of immune…”
Get full text

PREOPERATIVE PULMONARY FUNCTION AS A PREDICTOR OF RESPIRATORY COMPLICATIONS AND MORTALITY IN PATIENTS UNDERGOING LUNG CANCER RESECTION by FUJIU, KOICHI, KANNO, RYUZO, SUZUKI, HIROYUKI, SHIO, YUTAKA, HIGUCHI, MITSUNORI, OHSUGI, JUN, OISHI, AKIO, GOTOH, MITSUKAZU

“…Objective: We evaluated preoperative pulmonary function as a predictor of respiratory complications and mortality in patients undergoing lung cancer resection…”
Get full text

Predictive value of serum nitric oxide for bevacizumab response in patients with non-small cell lung cancer by Suzuki, Hiroyuki, Ohsugi, Jun, Hasegawa, Takeo, Yaginuma, Hiroshi, Okabe, Naoyuki, Muto, Satoshi, Owada, Yuki, Gotoh, Mitsukazu

“…Abstract only e19162 Background: Bevacizumab (BEV), an inhibitory monoclonal antibody to VEGF, is widely used to treat patients with non-small cell lung cancer…”
Get full text

Phase I trial of cancer vaccine with multiple peptides derived from novel onco-antigen and anti-angiogenic antigens for patients with advanced non-small cell lung cancer (NSCLC) by Suzuki, Hiroyuki, Hasegawa, Takeo, Ohsugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Yoshida, Koji, Tsunoda, Takuya, Nakamura, Yusuke, Gotoh, Mitsukazu

“…Abstract only e13015 Background: Two phase I clinical trials were conducted on patients with advanced or recurrent NSCLC to evaluate the safety, immunogenicity…”
Get full text

Recent advances in immunotherapy for non-small-cell lung cancer by Suzuki, Hiroyuki, Owada, Yuki, Watanabe, Yuzuru, Inoue, Takuya, Fukuharav, Mitsuro, Yamaura, Takumi, Mutoh, Satoshi, Okabe, Naoyuki, Yaginuma, Hiroshi, Hasegawa, Takeo, Yonechi, Atsushi, Ohsugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Gotoh, Mitsukazu

“…Despite of recent development in the field of molecular targeted therapies, lung cancer is a leading cause of cancer death in the world. Remarkable progress…”
Get full text

Carbohydrate status detecting by PNA is changeable through cancer prognosis from primary to metastatic nodal site: A possible prognostic factor in patient with node-positive lung adenocarcinoma by Shio, Yutaka, Suzuki, Hiroyuki, Kawaguchi, Takanori, Ohsugi, Jun, Higuchi, Mitsunori, Fujiu, Koichi, Kanno, Ryuzo, Ohishi, Akio, Gotoh, Mitsukazu

“…Summary Carbohydrates antigens in cancer cells are considered to be important molecules, which may play a critical role for metastasis. To elucidate the…”
Get full text

Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma by Suzuki, Hiroyuki, Kawaguchi, Takanori, Hasegawa, Takeo, Yonechi, Atsushi, Ohsugi, Jun, Higuchi, Mitsunori, Yamada, Fumihiko, Shio, Yutaka, Fujiu, Koichi, Kanno, Ryuzo, Ohishi, Akio, Gotoh, Mitsukazu

“…Prognostic value of p53 protein expression in node-negative lung adenocarcinoma is still controversy. The expression of p53 protein was examined…”
Get full text

Prediction of recurrence for non-small cell lung cancer by combined analysis of molecular markers and 18F 2-fluoro-2-deoxy-D-glucose positron emission tomography by Yonechi, Atsushi, Suzuki, Hiroyuki, Sakuma, Hideo, Higuchi, Mitsunori, Ohsugi, Jun, Okabe, Naoyuki, Muto, Satoshi, Teranishi, Yasushi, Gotoh, Mitsukazu

“…Numerous biomarkers have been reported to reflect prognosis in patients with non-small cell lung cancer, but most of them remain controversial in terms of the…”
Get more information

PREOPERATIVE PULMONARY FUNCTION AS A PREDICTOR OF RESPIRATORY COMPLICATIONS AND MORTALITY IN PATIENTS UNDERGOING LUNG CANCER RESECTION by FUJIU, KOICHI, KANNO, RYUZO, SUZUKI, HIROYUKI, SHIO, YUTAKA, HIGUCHI, MITSUNORI, OHSUGI, JUN, OISHI, AKIO, GOTOH, MITSUKAZU

Get full text